Evidence map›Paper›PMID 32544159›Full record

ArticlePLoS neglected tropical diseases2020

Multivariate time-series analysis of biomarkers from a dengue cohort offers new approaches for diagnosis and prognosis.

Baptiste Vasey, Anuraj H Shankar, Bobby Brooke Herrera, Aniuska Becerra, Kris Xhaja, Marion Echenagucia, Sara R Machado, Diana Caicedo, John Miller, Paolo Amedeo and 3 more

Abstract readClinical Study
In one paragraph

Article in PLoS neglected tropical diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Markers of prolonged hospitalisation in severe dengue.PLoS neglected tropical diseases · 2024
    Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Baptiste VaseyNuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom.
Anuraj H ShankarNuffield Department of Medicine, Centre for Tropical Medicine and Global Health, University of Oxford, Oxford, United Kingdom.
Bobby Brooke HerreraE25Bio Inc., Cambridge, Massachusetts, United States of America.
Aniuska BecerraCenter for Infectious Diseases and Vaccine Research, University of Massachusetts, Worcester, Massachusetts, United States of America.
Kris XhajaCenter for Infectious Diseases and Vaccine Research, University of Massachusetts, Worcester, Massachusetts, United States of America.
Marion EchenaguciaCentro Nacional de Hemofilia at Banco Municipal de Sangre, Universidad Central de Venezuela, Caracas, Venezuela.
Sara R MachadoDepartment of Health Policy, London School of Economics, London, United Kingdom.ORCID 0000-0002-9287-8165
Diana CaicedoPontificia Universidad Javeriana, Cali, Colombia.
John MillerJ. Craig Venter Institute, La Jolla, California, United States of America.
Paolo AmedeoJ. Craig Venter Institute, La Jolla, California, United States of America.
Elena N NaumovaFriedman School of Nutrition Science and Policy, Tufts University, Boston, Massachusetts, United States of America.
Irene BoschE25Bio Inc., Cambridge, Massachusetts, United States of America.ORCID 0000-0003-1352-5888
Norma Blumenfeld deBosch

Funding

PATHOGENESIS OF SEVERE DENGUE INFECTIONS IN VENEZUELAU01AI045440 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI ROTHMAN, ALAN L · 1999 to 2004
$2.3M
NIAID NIH HHS U01 AI045440
6 · The paper itself

Abstract

Dengue is a major public health problem worldwide with distinct clinical manifestations: an acute presentation (dengue fever, DF) similar to other febrile illnesses (OFI) and a more severe, life-threatening form (severe dengue, SD). Due to nonspecific clinical presentation during the early phase of dengue infection, differentiating DF from OFI has remained a challenge, and current methods to determine severity of dengue remain poor early predictors. We present a prospective clinical cohort study conducted in Caracas, Venezuela from 2001-2005, designed to determine whether clinical and hematological parameters could distinguish DF from OFI, and identify early prognostic biomarkers of SD. From 204 enrolled suspected dengue patients, there were 111 confirmed dengue cases. Piecewise mixed effects regression and nonparametric statistics were used to analyze longitudinal records. Decreased serum albumin and fibrinogen along with increased D-dimer, thrombin-antithrombin complex, activated partial thromboplastin time and thrombin time were prognostic of SD on the day of defervescence. In the febrile phase, the day-to-day rates of change in serum albumin and fibrinogen concentration, along with platelet counts, were significantly decreased in dengue patients compared to OFI, while the day-to-day rates of change of lymphocytes (%) and thrombin time were increased. In dengue patients, the absolute lymphocytes to neutrophils ratio showed specific temporal increase, enabling classification of dengue patients entering the critical phase with an area under the ROC curve of 0.79. Secondary dengue patients had elongation of Thrombin time compared to primary cases while the D-dimer formation (fibrinolysis marker) remained always lower for secondary compared to primary cases. Based on partial analysis of 31 viral complete genomes, a high frequency of C-to-T transitions located at the third codon position was observed, suggesting deamination events with five major hot spots of amino acid polymorphic sites outside in non-structural proteins. No association of severe outcome was statistically significant for any of the five major polymorphic sites found. This study offers an improved understanding of dengue hemostasis and a novel way of approaching dengue diagnosis and disease prognosis using piecewise mixed effect regression modeling. It also suggests that a better discrimination of the day of disease can improve the diagnostic and prognostic classification power of clinical variables using ROC curve analysis. The piecewise mixed effect regression model corroborated key early clinical determinants of disease, and offers a time-series approach for future vaccine and pathogenesis clinical studies.

Indexed as

AdolescentAdultAgedBiomarkersBiostatisticsBlood Chemical AnalysisChildChild, PreschoolDengueDiagnostic Tests, RoutineFemaleHumansMaleMiddle AgedPrognosisProspective StudiesBiomarkers

Identifiers

PMID32544159
PMCPMC7380649

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.